Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
the ONA take:
Actress Angelina Jolie announced Tuesday that she underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
Having lost her mother, grandmother, and aunt to cancer, Jolie underwent a double mastectomy 2 years ago over similar concerns. Jolie opted to have her ovaries and fallopian tubes last weeks after a blood test revealed that she may be in the early stages of cancer.
After Jolie underwent the procedure to remove both of her breasts, the pros and cons of preventative measures were pushed into the spotlight, ultimately causing the "Angelina Jolie effect," in which there was an increase in women with genuine concerns about their family history of breast cancer seeking advice from health care professionals. Her announcement could produce the same effect for women concerned about their risk of ovarian cancer.
Further tests showed that the actress was not actually in the early stages of cancer, but she opted for the surgery before of her family history and because she carries the BRCA1 gene mutation that increases her risk of developing ovarian cancer by 50% and breast cancer by 87%.
Actress Angelina Jolie underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|